Evidence map›Paper›PMID 27096536›Full record

ArticleCell cycle (Georgetown, Tex.)2016

Yin and yang of 4E-BP1 in cancer.

Ren Wang, Shridar Ganesan, X F Steven Zheng

Abstract readComment
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. MicroRNA-31 induced byiScience · 2023
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ren Wanga State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center , Guangzhou , China.
Shridar Ganesanb Rutgers Cancer Institute of New Jersey, Rutgers, the State University of New Jersey , New Brunswick , NJ , USA.
X F Steven Zhengb Rutgers Cancer Institute of New Jersey, Rutgers, the State University of New Jersey , New Brunswick , NJ , USA.

Funding

Mechanism of Action by mTOR Kinase Inhibitors in Colorectal CancerR01CA166575 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ZHENG, STEVEN · 2012 to 2016
$1.6M
Role of Rab1 in Cell Growth and CancerR01CA173519 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI ZHENG, STEVEN · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA166575NCI NIH HHS R01 CA173519
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsPhosphoproteinsHumansPhosphorylationTOR Serine-Threonine KinasesPhosphoproteinsTOR Serine-Threonine Kinases4E-BP1cancerkinasemTORtranslation

Identifiers

PMID27096536
PMCPMC4934074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.